Direct comparison of insulin lispro and aspart shows small differences in plasma insulin profiles after subcutaneous injection in type 1 diabetes

被引：52

作者：

Hedman, CA

Lindstrom, T

Arnqvist, HJ

机构：

[1] Linkoping Univ, Dept Med & Care, Div Internal Med, Linkoping, Sweden

[2] Linkoping Univ, Fac Hlth Sci, Dept Biomed & Surg, Div Cellbiol, Linkoping, Sweden

来源：

DIABETES CARE | 2001年 / 24卷 / 06期

关键词：

D O I：

10.2337/diacare.24.6.1120

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1120 / 1121

页数：2

共 8 条

[1] LACK OF GROWTH-HORMONE EFFECT ON INSULIN-ASSOCIATED SUPPRESSION OF INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-1 IN HUMANS [J].

CONOVER, CA ;

BUTLER, PC ;

WANG, M ;

RIZZA, RA ;

LEE, PDK .

DIABETES, 1990, 39 (10) :1251-1256

[2]

HEDMAN CA, IN PRESS CLIN ENDOCR

[3] ACTION PROFILE OF THE RAPID ACTING INSULIN ANALOG - HUMAN INSULIN B28ASP [J].

HEINEMANN, L ;

HEISE, T ;

JORGENSEN, LN ;

STARKE, AAR .

DIABETIC MEDICINE, 1993, 10 (06) :535-539

[4] Comparative pharmacokinetics and pharmacodynamics of the novel rapid-acting insulin analogue, insulin aspart, in healthy volunteers [J].

Home, PD ;

Barriocanal, L ;

Lindholm, A .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1999, 55 (03) :199-203

[5] COMPARISON OF SUBCUTANEOUS SOLUBLE HUMAN INSULIN AND INSULIN ANALOGS (ASPB9,GLUB27-ASPB10-ASPB28) ON MEAL-RELATED PLASMA-GLUCOSE EXCURSIONS IN TYPE-I DIABETIC SUBJECTS [J].

KANG, S ;

CREAGH, FM ;

PETERS, JR ;

BRANGE, J ;

VOLUND, A ;

OWENS, DR .

DIABETES CARE, 1991, 14 (07) :571-577

[6] Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use [J].

Kurtzhals, P ;

Schäffer, L ;

Sorensen, A ;

Kristensen, C ;

Jonassen, I ;

Schmid, C ;

Trüb, T .

DIABETES, 2000, 49 (06) :999-1005

[7]

Lefèbvre P, 1998, DIABETIC MED, V15, pS63, DOI 10.1002/(SICI)1096-9136(1998120)15:4+<S63::AID-DIA737>3.3.CO

[8]

2-Z

← 1 →